Rivaroxaban for the prevention of venous thromboembolism
| Status: |
History |
| Expected date of issue: |
April 2009 |
| Wave: |
17 |
| Process: |
STA |
| Topic area:
|
NICE project team
| Executive Lead: |
Gillian Leng
|
| Technical Lead: |
David Chandiwana
|
| Communications manager: |
Kristin O'Leary
|
| Project manager: |
Bijal Chandarana
|
Provisional schedule
| Closing date for invited submissions / evidence submission: |
08 October 2008 |
| 1st appraisal committee meeting: |
22 January 2009 |
Consultees and Commentators
|
| Consultees |
Commentators (no right to submit or appeal) |
|
Manufacturers / Sponsors
- Bayer Schering Pharma (rivaroxiban)
Patient / Carer Groups
- Afiya Trust
- Age Concern England
- Anticoagulation Europe
- Black Health Agency
- British Ethnic Health Awareness Foundation (BEHAF)
- British Lung Foundation
- Chinese National Healthy Living Centre
- Confederation of Indian Organisations
- Counsel and Care
- DVT Awareness Campaign
- Equalities National Council
- Help the Aged
- Lifeblood: The Thrombosis Charity
- Muslim Council of Great Britain
- Muslim Health Network
- South Asian Health Foundation
- Specialised Healthcare Alliance
Professional Groups
- Anticoagulation Specialist Association
- Association of Surgeons of Great Britain and Ireland
- British Association for Service to the Elderly
- British Association for Surgery of the Knee
- British Geriatrics Society
- British Orthopaedic Association
- British Society for Haematology
- British Society for Haemostasis and Thrombosis
- British Thoracic Society
- Clinical Leaders of Thrombosis (CLOT)
- Royal College of Anaesthetists
- Royal College of General Practitioners
- Royal College of Nursing
- Royal College of Pathologists
- Royal College of Physicians
- Royal College of Surgeons
- Royal Pharmaceutical Society
- Royal Society of Medicine - Forum on Intellectual Disabilities
- Society for Vascular Technology
- Society for Vascular Ultrasound
- Society of Vascular Nurses
- United Kingdom Clinical Pharmacy Association
- Vascular Society of Great Britain and Ireland
Others
- Coventry PCT
- Department of Health
- Hammersmith and Fulham PCT
- Welsh Assembly Government
|
General
- Age Concern Cymru
- Board of Community Health Councils in Wales
- British National Formulary
- Department of Health, Social Services and Public Safety for Northern Ireland
- Medicines and Healthcare products Regulatory Agency
- National Association for Primary Care
- National Public Health Service for Wales
- NHS Alliance
- NHS Confederation
- NHS Purchasing and Supply Agency
- NHS Quality Improvement Scotland
- Scottish Medicines Consortium
Comparator manufacturer(s)
- Amdipharm (bemiparin sodium)
- GlaxoSmithKline (fondaparinux sodium)
- Leo Laboratories (tinzaparin sodium)
- Pfizer (dalteparin sodium)
- Sanofi-Aventis (enoxaparin sodium)
- Boehringer Ingelheim Ltd
Relevant research groups
- Antithrombotic Trialists' (ATT) Collaboration
- Cochrane Peripheral Vascular Disease Group
- Policy Research Institute on Ageing and Ethnicity
- Research Institute for the Care of the Elderly
- Thrombosis Research Institute
Evidence Review Group
- School of Health & Related Research Sheffield (ScHARR)
- National Coordinating Centre for Health Technology Assessment
Associated Guideline Groups
- National Collaborating Centre for Acute Care
Associated Public Health Groups
|
|
Key documents
|
|
|
This page was last updated: 21 October 2008 |